Management of bladder cancer

Minerva Urol Nefrol. 2008 Dec;60(4):255-64.

Abstract

Bladder cancer is the fourth most common cancer in men and is increasing in incidence in women as well. Bladder cancer has a broad range of behavior and presentations, with different prognoses and treatments. Laboratory research has made strides in elucidating pathways of this cancer, and identifying novel therapeutic targets. This short review provides a summary of the current knowledge of the management of bladder cancer.

Publication types

  • Review

MeSH terms

  • BCG Vaccine / administration & dosage
  • Carcinoma in Situ / diagnosis
  • Carcinoma in Situ / therapy
  • Carcinoma, Papillary / diagnosis
  • Carcinoma, Papillary / therapy
  • Chemotherapy, Adjuvant
  • Cystectomy
  • Female
  • Humans
  • Injections, Intralesional
  • Male
  • Meta-Analysis as Topic
  • Prognosis
  • Radiotherapy, Adjuvant
  • Risk Factors
  • Treatment Outcome
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / therapy*

Substances

  • BCG Vaccine